期刊文献+

复合型PSA与总PSA比值在前列腺癌诊断中的应用 被引量:5

The role of the ratio of complexed PSA and total PSA in diagnosis of prostate cancer
下载PDF
导出
摘要 目的 探讨复合型PSA(CPSA)与总PSA(TPSA)比值在前列腺癌(PCa)诊断的应用价值。方法 采用化学发光免疫分析法(CLIA)测定2 78例患者(其中PCa 6 3例,BPH2 15例)与112例正常健康体检男性的血清TPSA、CPSA水平,并计算TPSA/CPSA(C/T)比值。结果 BPH组、PCa组TPSA、CPSA水平均显著高于正常对照组(P <0 .0 1) ,PCa组的血清TPSA、CPSA、C/T水平显著高于BPH组(P <0 . 0 1)。TPSA <4 μg/L时各组间TPSA、CPSA、C/T均无显著差异(P>0 .0 5 ) ;4 μg/L≤TPSA≤10 μg/L时各组间TPSA、CPSA均无显著差异(P >0 .0 5 ) ,PCa组C/T显著高于BPH组(P <0 . 0 1) ;TPSA >10 μg/L时PCa组TPSA、CPSA、C/T均显著高于BPH组(P <0 . 0 1)。C/T以0 . 80为标准对PCa诊断具有较好的敏感性、特异性及实验有效率。结论 C/T在PCa诊断上具有重要临床价值,有很大可能成为新的较有意义的指标为PCa诊断提供更好的依据。 Objective To investigate the diagnostic value of the ratio of complexed PSA(CPSA) and total PSA(TPSA) in prostate cancer(PCa). Methods The serum TPSA and CPSA levels of 278 patients(63 patients with PCa, 215 patients with BPH) and 112 healthy men as normal control were determined by chemiluminescent immunoassay(CLIA). Results TPSA, CPSA of BPH and PCa were all significantly higher than in normal control( P <0.01), and TPSA, CPSA and C/T of PCa were significantly higher than of BPH( P <0.01). When TPSA<4 μg/L, the differences of TPSA, CPSA and C/T in three groups were not significant( P >0.05); When 4 μg/L≤TPSA≤10 μg/L, the differences of TPSA, CPSA in three groups were not significant( P >0.05), but C/T of PCa was significantly higher than of BPH( P <0.01); When TPSA>10 ug/L, TPSA, CPSA and C/T of PCa were significantly higher than of BPH( P <0.01). As the C/T cut off value was 0.80, sensitivity, specificity and experimental validity for the diagnosis of PCa were satisfactory. Conclusion C/T is of important clinical value in the diagnosis of PCa, and may be a new and significant indicator to provide a better basis for the diagnosis of PCa.
出处 《中国实验诊断学》 2005年第2期210-212,共3页 Chinese Journal of Laboratory Diagnosis
关键词 总前列腺特异性抗原(TPSA) 复合型前列腺特异性抗原(CPSA) 化学发光免疫分析法(CLIA) 前列腺癌(Pca) 前列腺增生(BPH) total prostate specific antigen(TPSA) complexed prostate specific antigen(CPSA) chemiluminescent immunoassay(CLIA) prostate cancer(PCa) benign prostate hyperplasia(BPH)
  • 相关文献

参考文献5

二级参考文献34

  • 1王子明,刘大鹏,赵丽华,安良.年龄对血清前列腺特异性抗原浓度的影响[J].中华外科杂志,1996,34(6):368-369. 被引量:5
  • 2Louha M;Roussin k;Ganne n.Spontanceus and intiogenic spreading of liver-derived cells into peripheral blood of patients liver cancer[J],1997(04).
  • 3Papsidero LD;Wang MC;Valanzuela LA.A Prostate specific antigen in sera of prostate cancer patient,1980(10).
  • 4Zhang WM;Finne p;Leinonen J.Measurement of the complex between prostate-specific antigen and alpha 1-protease inhibitor in surm,1999.
  • 5Zhang WM;Finnel P;Leinonen J.Determinatation of prostate-specific antigen complexed with a2-macroglobulin in serm increase the specificity of free to total PSA for prostate cancer[J],2000(2).
  • 6Brandle E;Hautmann O;Bachem M.serum half life time determination of free and total prostate-specific antigen following radical prostatectomy-a critical assessment[J],1999(4).
  • 7Lilja H;Haese A;Bjork T.Significance and metabolism of complexed and noncomplexed prostate-specific antigen forms and human glandular kallikrein-2 in clinically localized prostate cancer before and after radical prostatectomy[J],1999.
  • 8Horninger W;Ressigil A;Rogatsch H.Prostate cancer screening in the Tyrol Austra,experience and results[J],2000.
  • 9Hudson MA.Clinical use of prostate-specific antigen in patients with prostatic cancer,1989.
  • 10McNeal JE;Redwine ea;FREIHA FS.Zonal distribution of prostate adenocarcinoma correlation with histologic pattern and direction of spread[J],1988.

共引文献40

同被引文献22

  • 1张尧,江军,靳凤烁,王洛夫,兰卫华.血清TPSA与F/T检测在前列腺良、恶性病变诊断中的价值及其影响因素[J].临床泌尿外科杂志,2005,20(3):153-155. 被引量:6
  • 2魏丽琴,孙文伟,马庆杰,李扬.DELFIA检测血清PSA、fPSA及fPSA/PSA在前列腺疾病诊断中的应用[J].吉林大学学报(医学版),2006,32(5):851-853. 被引量:5
  • 3薛忠光.PSA、cPSA检测和骨显像对前列腺癌早期骨转移的诊断价值[J].放射免疫学杂志,2007,20(1):74-76. 被引量:4
  • 4Smith DS. Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection [ J ]. J Urol, 1999,151 : 1283.
  • 5furuya Y,Akakura k,lto H. Value of f/tPSA ratio for detection and staging of PCa[ J ]. International Joumal of Clinical Oncology,2000,5( 1 ) :8.
  • 6Kuwahara M, Toehigi T, Kawamura S, et al. Mass screening for prostate cancer:a oxnparative study in Natori, Japan and Changchun, China[J]. Urology,2003,61 (1) : 137.
  • 7Filella X, Truan D. Aleover J, et al. Comparison of several combinations of fl~SA, cPSA, and tPSAin the diagnosis of PCain patients with urologic symptorns[J]. Journal of Urology,2004,63(6) :1103.
  • 8Christensson A, Bjork T, Nilsson O, et al. Serum prostate specific antigen complexed to alpha 1-antichymortypsin as an indicator of prostate cancer. J Urol, 1993, 150(1) : 100-105.
  • 9Jung K, Elgeti U, Lein M, et al. Ratio of free or complexed prostate specific antigen ( PSA ) to total PSA : Which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer? Clin Chem, 2000, 46( 1 ) : 55-62.
  • 10Bunting PS, DeBoer G, Choo R, et al. Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation. Clin Biochem, 2002, 35(6): 471-475.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部